Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase ‐4 inhibitor in pre‐diabetic rats

ConclusionsFGF21 exerts better metabolic regulation and inflammation reduction than vildagliptin. However, FGF21 and vildagliptin shared a similar efficacy for cardioprotection by improving HRV and LV function.This article is protected by copyright. All rights reserved.

Source: Cardiovascular Therapeutics - April 1, 2017 Category: Cardiology Authors: Pongpan Tanajak, Piangkwan Sa ‐nguanmoo, Nattayaporn Apaijai, Xiaojie Wang, Guang Liang, Xiaokun Li, Chao Jiang, Siriporn C. Chattipakorn, Nipon Chattipakorn Tags: Original Research Article Source Type: research